Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
Arthrosi’s investigational gout treatment is currently being evaluated in global studies
Read More
Author: Esme Needham
Jesper Hagberg
BICO has appointed Jesper Hagberg as Chief Operations & Digital Officer
Read More
Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
The two companies aim to reduce administrative burden and speed up drug delivery
Read More
Title21 Health Solutions joins the Blood and Cells Advocacy Roster
The blood industry plays a vital role in supporting the development of advanced therapies
Read More
NADMED launches $30,000 metabolomics research award
Winners will receive metabolomics kits, expert consultation and measurement services
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
